Vaginal health
Evidence review
WHC definitive guide
The Vagina After 40: What Really Changes — and What Women Are Rarely Told
A connected guide to vaginal, vulval, urinary, pelvic-floor and sexual health through perimenopause and beyond.
A woman may expect hot flushes or broken sleep. She may not expect sex to start hurting, her vulva to burn, or urinary urgency to shape every journey. These symptoms deserve open discussion—but they should not automatically be labelled “just menopause”.
Key takeaways
- ✓The vulva, vagina, urethra and bladder, pelvic floor, and sexual function are connected—but not interchangeable.
- ✓Menopausal hormonal change can contribute to genitourinary syndrome of menopause (GSM), but GSM is not the explanation for every symptom.
- ✓Pain, repeated “UTIs”, persistent burning, visible skin change and unexplained bleeding should not be repeatedly self-treated without finding the cause.
- ✓Local vaginal oestrogen, systemic HRT, lubricants, moisturisers and pelvic-floor physiotherapy have different roles.
- ✓NICE says vaginal laser for menopausal genitourinary symptoms should be offered only within a randomised controlled trial.
Knowing exactly where and how a symptom occurs is the first step towards useful assessment.
Executive summary
Common enough to discuss; varied enough to assess
Menopausal hormonal change can affect the lower genital and urinary tract. The term GSM brings vaginal, vulval, sexual and urinary symptoms into one useful framework. Yet infection, vulval skin disease, pelvic-floor dysfunction, medication effects and other gynaecological or urological conditions may overlap.
The right questions are: what changed, where is it happening, what could explain it, and does it need examination or testing? Treatment should follow that reasoning—not a promise that one product or procedure fixes everything.
Five connected systems
Name the location
External itch, entry pain, deep pelvic pain, urethral burning and internal dryness raise different questions. Precise language helps a clinician decide whether examination, urine testing, swabs or another pathway is appropriate.
Hormones and tissue
What oestrogen can—and cannot—explain
Oestrogen-responsive tissue
The vulva, vagina, urethra and bladder contain hormone-responsive tissues. Falling or fluctuating oestrogen can influence epithelial maturation, tissue resilience, moisture, elasticity, blood flow and the local microbial environment. Women vary: visible change and symptom severity do not always match.Before menopause, oestrogen supports vaginal epithelial maturation and glycogen availability. Lactobacillus species often help maintain an acidic environment. After menopause, research frequently finds fewer lactobacilli, a higher pH and more microbial diversity—but symptoms do not map neatly to a single microbial pattern.
GSM is an umbrella, not a catch-all
Genitourinary syndrome of menopause describes vaginal, vulval, sexual and urinary symptoms and changes associated with menopausal hormonal decline. Dryness, irritation, burning, painful sex and discomfort when urinating may belong within it.Itching can also be thrush, eczema, contact dermatitis or lichen sclerosus. Burning can reflect irritation, infection, vulvodynia or pelvic-floor pain. More than one cause may be present.
What the biological pathway means—and what it does not
Lower oestrogen can influence epithelial thickness, maturation and blood flow, while changes in glycogen availability can alter the conditions in which vaginal microbes live. A higher pH and reduced Lactobacillus abundance are common group-level findings after menopause. They do not occur identically in every woman, and they do not create a direct one-microbe, one-symptom equation.Other influences include antibiotics, diabetes, immune function, sexual activity, medicines, hygiene practices and individual biology. Some women have tissue changes on examination with few symptoms; others have substantial discomfort without dramatic visible change. The person’s experience and goals therefore matter alongside clinical findings.A pH test cannot diagnose every cause of dryness, discharge or burning. Blood, semen and infection can affect pH, and a test does not examine vulval skin or pelvic-floor function. Mechanism can guide care, but it should not become a home diagnostic shortcut.
Microbiome reality check
An ecosystem, not a cleaning problem
Do not douche or routinely cleanse inside the vagina. Commercial “balancing” claims often outrun evidence. Persistent odour, discharge, itch or burning is better assessed than repeatedly treated with washes, probiotics or supplements.
What may change in the vagina and vulva
The vagina
Some women notice less spontaneous moisture or lubrication, soreness, burning, reduced elasticity or friction with penetration. Tissue can feel delicate and minor trauma may cause spotting. The phrase “the vagina shrinks” is misleading: reduced stretch, avoidance because of pain, pelvic-floor guarding, surgery, radiotherapy and skin disease can all influence comfort or capacity.A new discharge, odour or marked irritation should not automatically be assigned to low oestrogen. Internal cleansing is not a remedy.
The vulva
External skin may become drier or more sensitive. Products, pads or fabrics that were previously comfortable may irritate. Ageing and hormonal change can affect tissue fullness and appearance, but wide normal variation remains.Persistent whitening, thickening, redness, fissures, sores, ulcers or architectural change needs examination. Lichen sclerosus and contact dermatitis require different care from vaginal dryness.
Normal variation is not a cosmetic defect
A changing appearance alone does not mean disease or create a need for “rejuvenation”. Persistent symptoms should not be dismissed, but neither should ageing anatomy be framed as broken.
The bladder, urethra and pelvic floor
UTI is not the only explanation
Menopausal genitourinary change may be associated with urgency, frequency, discomfort when passing urine and recurrent UTI. A confirmed bacterial infection is different from a UTI-like sensation. GSM, urethral irritation, overactive bladder, pelvic-floor dysfunction and other conditions can overlap, while genuine infection must not be dismissed.Repeated antibiotics without confirming the pattern may miss the cause; assuming every episode is hormonal may miss infection. Review symptom timing, urine results, recurrence, vaginal and vulval symptoms, emptying and relevant medical history. NICE includes vaginal oestrogen in the recurrent-UTI prevention conversation after behavioural measures are ineffective or inappropriate.A person may have GSM and a bacterial UTI at the same time. New severe urinary symptoms, fever, pain in the side or back, blood in urine or feeling acutely unwell require appropriate clinical advice rather than a self-diagnosis from this article. At the other end of the spectrum, long-standing urgency without infection may be shaped by bladder habits, fluid timing, overactive bladder or pelvic-floor response.Nocturia—waking to pass urine—also needs context. Sleep disturbance, fluid intake, medicines and medical conditions may contribute. Menopause can be part of the story without being the only explanation. Likewise, stress leakage with coughing or exercise and urgency leakage represent different patterns and may need different management.Pelvic-floor function is not just strength
Pregnancy and birth, ageing, connective tissue, chronic cough, constipation, body weight, activity, surgery, pain and neuromuscular coordination all matter. Reduced strength can contribute to stress leakage, but an overactive floor can contribute to urgency, entry pain and difficulty relaxing.Pelvic-floor guarding is often protective. If the entrance to the vagina has repeatedly felt sore, the muscles may contract before touch. That protection can outlast the original trigger. Simply trying harder to relax may not be enough; graded, consent-based work can help restore coordination and confidence.Assessment may consider breathing, abdominal pressure, bowel habits, bladder emptying, scar tissue, movement, muscle tenderness and the ability both to contract and let go. A programme for stress incontinence may emphasise strength and endurance; a programme for pain may begin with down-training, relaxation and reducing threat.Pelvic-health physiotherapy can assess both contraction and relaxation. NICE says training should be supervised by an appropriately skilled professional and tailored to ability, discomfort and goals. Devices, internal assessment or manual techniques are never automatic; consent and alternatives should be discussed.
Systemic HRT and local vaginal oestrogen
Systemic HRT—tablets, patches, gel or spray—is used for symptoms across the body. Local vaginal oestrogen delivers a low dose directly to the vaginal area for genitourinary symptoms. They are not competitors, and improvement in hot flushes does not guarantee that local symptoms will resolve.| Treatment | Main role | Important distinction |
|---|---|---|
| Systemic HRT | Whole-body menopause symptoms where appropriate | May not fully resolve vaginal or urinary symptoms |
| Local vaginal oestrogen | Vaginal, vulval and relevant urinary symptoms | Can be used alone or alongside systemic HRT where suitable |
Breast-cancer history requires an individual discussion, not a slogan. NICE recommends non-hormonal moisturisers or lubricants first; vaginal oestrogen may be considered if symptoms continue. People taking aromatase inhibitors should work with their breast-cancer specialist.
Lubricants and moisturisers are not the same
Lubricant
Used around sexual activity, examination or insertion to reduce friction. It does not diagnose the reason for dryness or pain. Bases and ingredients vary, and compatibility with condoms or devices should be checked.Vaginal moisturiser
Used regularly according to directions to support ongoing moisture and comfort. It is not the same as an ordinary body moisturiser. Stop and seek advice if a product causes persistent stinging or irritation.A person may use one, both or neither. Dryness does not prove low desire, and lubrication does not prove arousal. Persistent pain, bleeding, discharge or recurrent urinary symptoms still need assessment.
Why a gradual change may feel sudden
Hormonal and tissue change does not follow a tidy calendar. Perimenopause includes fluctuating hormones, and symptoms may appear intermittently before becoming persistent. A woman may first notice discomfort only during longer sexual activity, after illness, or when arousal has had less time to build. Later, the same tissue may feel dry during ordinary activity. A personal threshold has been crossed even if the underlying change was gradual.Behaviour can hide progression. Someone who gradually avoids penetration may not realise entry pain has worsened. Someone who empties her bladder “just in case” may accommodate increasing urgency until a disrupted journey exposes it. Repeatedly changing washes and treatments can obscure which symptoms are hormonal and which are irritant.Life events can reveal a previously compensated problem: a new relationship, return to sex, a different exercise routine, surgery, antibiotics, new medication or severe stress. Timing offers a clue, not proof. A chronological account—what changed, where, how often and after which events—can prevent the menopause label from erasing relevant history.Questions worth recording
- Did the symptom start before periods changed?
- Is it external, at entry, deep, urinary or generalised?
- Is it constant or linked to sex, products, exercise or infection?
- Which tests confirmed previous diagnoses?
- What improved it, and what made it worse?
When the standard menopause story does not fit
Some contexts widen the assessment and change the practical options.
Surgery and cancer treatment
Surgical removal of the ovaries and some cancer treatments can produce abrupt hormonal change. Chemotherapy, pelvic radiotherapy, endocrine therapy and pelvic surgery may also affect tissue, nerves, bladder, bowel or scarring. These presentations often need coordinated specialist care rather than a routine GSM assumption.Health and medication
Diabetes, Sjögren’s syndrome and some medicines may contribute to dryness or infection risk. Antidepressants and other medicines can affect desire, arousal or orgasm. Neurological conditions can alter bladder and pelvic-floor function. Menopause may coexist with each of these.Practical access
Disability, dexterity, pain or previous trauma can make vaginal applicators difficult. Different formulations and selected oral options may be discussed. Practical ability, consent and comfort belong in shared decision-making.Contraception and sexual health
Pregnancy risk does not end as soon as periods become irregular, and STI testing remains relevant to exposure. Pain discussions may include safety, relationship context and trauma-informed care without presuming any one cause.From symptom to sensible next step
The same starting symptom can lead to different clinical questions. These pathways are not self-diagnostic instructions; they show why a careful history is more useful than repeatedly reaching for the same treatment.Dryness or friction
Dryness is not proof of low desire, and more foreplay is not a complete answer when tissue has become hormonally responsive or painful.
Burning or itching
Repeatedly treating presumed thrush without confirmation may irritate tissue and delay a different diagnosis.
Pain during sex
Pause painful penetration. Supporting comfort and intimacy while assessment proceeds is preferable to reinforcing a pain-and-guarding cycle.
Urgency, frequency or urinary burning
Vaginal oestrogen may belong in prevention for recurrent UTI in the menopause context; it does not replace assessment of an acute episode.
Bleeding or visible change
Do not let a plausible GSM explanation close the assessment before important alternatives are considered.
Sexual function: separate the pieces
Desire, arousal, lubrication, sensation, orgasm and pain are not interchangeable.
Desire is not lubrication
A woman may feel mentally aroused yet produce less lubrication. Menopause does not inevitably reduce libido or prevent orgasm. Sleep, mood, stress, relationships, medicines and other conditions may be as relevant as hormones.
Pain is not a diagnosis
Entry pain, burning, tearing sensations and deep pain have different possible causes. Do not keep forcing painful penetration. Lubricant can reduce friction but cannot treat every fissure, skin condition, pelvic-floor problem or cause of deep pain.
How the sexual response can change
Desire means wanting sexual activity. Arousal is the mental and physical response to stimulation. Lubrication is one physical response and may be affected by hormonal change or medicines even when arousal is present. Sensation describes how touch is experienced, while orgasm is a distinct nervous-system, blood-flow and muscular event.Menopause does not inevitably reduce desire or remove orgasm. Some women notice little change; some feel freer after periods and pregnancy risk end; others experience lower desire, altered arousal, less lubrication, pain or a different orgasm. Sleep loss, mood, stress, relationship context, body image, illness, medication and previous sexual experiences may be as relevant as hormones.Pain can alter the whole sequence. If penetration hurts repeatedly, the nervous system can anticipate danger before contact. Arousal becomes harder, pelvic-floor muscles guard and the next attempt may hurt more. That response is not imaginary and is not resolved by being told to “relax”. Treatment may need to address tissue, muscle, nerves and the emotional consequences together.Sexual goals vary. Some people want comfortable penetration, while others want relief from daily soreness, confidence during exercise or non-penetrative intimacy without fear. Management should serve the person’s goal, not assume that intercourse is the measure of success.
Pain location changes the questions
- Superficial or entry pain may relate to dryness, fragile tissue, fissuring, vulval skin disease, vestibular pain or pelvic-floor guarding.
- Burning can occur with irritation, infection, GSM, nerve-related pain or a dermatosis.
- Tearing or splitting sensations deserve examination for fissures, fragile tissue and vulval skin conditions.
- Deep pain can have pelvic-floor, gynaecological, bladder, bowel or musculoskeletal causes. Vaginal dryness alone does not explain it.
- Persistent vulval pain may need a specialist vulval and pain assessment rather than repeated treatment for infection.
Pausing penetration, exploring comfortable forms of intimacy and finding the cause is more useful than pushing through. A lubricant helps friction; it does not diagnose the pain.
Is it GSM, thrush, BV, a UTI—or something else?
| Pattern | May include | Why checking matters |
|---|---|---|
| GSM | Dryness, burning, irritation, entry pain, urinary discomfort | Overlaps with infection, dermatoses and pelvic-floor dysfunction |
| Infection | Itch, discharge, odour, dysuria or urgency depending on type | Swabs or urine assessment may guide targeted treatment |
| Contact dermatitis | External itch, redness or burning linked to products | Repeated topical treatment can worsen irritation |
| Vulval dermatosis | Persistent itch, fissures or visible skin change | Lichen sclerosus and other conditions need examination |
| Pelvic-floor dysfunction | Guarding, entry pain, urgency, pressure or poor relaxation | May need coordination and relaxation rather than strength alone |
This table cannot diagnose an individual. Sexually transmitted infection remains relevant according to exposure, and deep pain, bleeding or lesions may require other gynaecological or urological assessment.
What a useful assessment may include
Assessment starts with the story: when symptoms began; whether they are constant or triggered; exactly where they occur; menstrual and menopause history; medicines and hormones; products contacting the area; sexual context; and whether previous urine or swab results actually confirmed infection.Examination may be useful for visible vulval change, fissures, fragile tissue, discharge, pain or uncertainty about the source. Testing is selective. Urine testing suits a urinary pattern; swabs may help when infection is possible; STI tests follow exposure; and bleeding, deep pain or other findings may require referral or imaging.The goal is not to perform every test. It is to avoid treating an assumption. A short symptom record can help: note triggers, location, products, medicines, test results and what made symptoms better or worse.
Evidence-based management
A hierarchy guided by symptoms and assessment—not a miracle menu.
1. Clarify the diagnosis and reduce irritation
Locate symptoms, review triggers, avoid douching and unnecessary fragrance, and treat confirmed infection or a diagnosed skin condition.
2. Use lubricants and moisturisers for their correct roles
Lubricants reduce friction around sex. Vaginal moisturisers are used regularly for ongoing moisture and comfort. Either can irritate some people.
3. Consider local vaginal oestrogen
For a personal breast-cancer history, NICE recommends non-hormonal options first, then individual consideration; people taking aromatase inhibitors should work with a breast-cancer specialist.
4. Include pelvic-health care and selected prescriptions
Pelvic-floor treatment should match weakness, guarding or coordination. NICE also lists prasterone when vaginal oestrogen or non-hormonal products are ineffective or not tolerated, and ospemifene when local treatment is impractical.
The plan should remain reviewable
Treatment response is useful information. If a lubricant removes friction but burning remains, there may be more than one contributor. If vaginal oestrogen improves dryness but entry pain continues, pelvic-floor guarding, a dermatosis or another pain mechanism may still need attention. If treatment for a presumed infection repeatedly fails, the diagnosis deserves review.Formulation and practical use matter. Vaginal oestrogen is available as cream, gel, tablet, pessary or ring. Dexterity, pain, disability, preference, product ingredients and availability can influence what is realistic. A treatment is not effective in practice if the person cannot or does not wish to use it.Non-hormonal choices should not be described as doing nothing, and hormonal treatment should not be presented as compulsory. Shared decision-making includes symptom burden, evidence, personal medical history, priorities and tolerance for uncertainty.Treatment also needs time appropriate to the option being used. A lubricant acts during use; tissue-directed treatment may take longer. Worsening, changing or persistent symptoms should prompt reassessment rather than automatic escalation.
Where laser and regenerative treatments fit
Current UK position
NICE says vaginal laser for menopausal genitourinary symptoms should be offered only within a randomised controlled trial. Its committee found the evidence base too small, noted potential harm such as scarring and found it not cost-effective.
The responsible order is medical and conservative options first. A selected procedure, if considered for an appropriate indication, should follow assessment and an informed discussion of evidence, alternatives, uncertainty and realistic expectations.
What not to ignore
Arrange assessment for persistent or worsening pain, repeated symptoms despite self-care, visible vulval change, sores or fissures, unusual discharge, recurrent confirmed UTIs, difficulty passing urine, pelvic pressure or painful sex that continues.
Any vaginal bleeding after menopause needs to be checked by a GP, even if it happens once or is only spotting.
Your intimate-health plan after 40
- Know your baseline and notice persistent change.
- Name the location and sensation.
- Protect vulval skin and avoid unnecessary irritants.
- Match lubricants and moisturisers to their distinct jobs.
- Include pelvic-floor relaxation, coordination or strengthening as appropriate.
- Discuss local and systemic hormonal options without confusing them.
- Investigate recurrent, unusual or persistent symptoms.
- Reassess if treatment does not help.
- Expect shared decision-making, not one compulsory treatment.
What not to do
- Do not douche or try to disinfect the vagina. Internal cleansing is unnecessary and may irritate tissue or disrupt its ecology.
- Do not assume repeated irritation is always thrush. Repeated antifungal treatment can obscure infection testing, aggravate skin and delay diagnosis of GSM or a dermatosis.
- Do not force painful penetration. Pain is information. Lubricant may reduce friction but cannot treat every fissure, skin condition, deep pain cause or guarded pelvic floor.
- Do not assume urinary burning always means infection—or never means infection. Look at the pattern and test where appropriate.
- Do not use heavily perfumed products on sensitive vulval tissue. Notice whether washes, wipes, pads, detergents or topical treatments coincide with symptoms.
- Do not accept “rejuvenation” as an evidence claim. Ask which indication was studied, against what comparator, for how long and with what harms recorded.
Everyday care without making the vulva a project
Gentle care does not require a complicated routine. Avoid repeatedly scrubbing sore tissue. If tight seams, prolonged damp clothing or a particular product clearly worsen symptoms, adjusting them is reasonable. This does not mean every woman must follow a restrictive set of clothing, exercise or sexual rules.Sexual comfort can be supported without making penetration the goal. More time for arousal, different positions, non-penetrative intimacy and stopping when pain begins may help prevent a pain-guarding cycle while the cause is assessed.There is no medical duty to have penetrative sex to keep the vagina “young”. Care should follow the person’s symptoms, values and goals.
Menopause may change intimate tissues and function, but women should neither be frightened by every change nor expected to tolerate persistent symptoms in silence. Understanding what may be happening—and what else needs consideration—makes intimate health after 40 far less mysterious.Good care does not begin by selling a procedure or by insisting that every change needs treatment. It begins with language: vulva or vagina, entry pain or deep pain, urgency or confirmed infection, desire or lubrication. That language turns an embarrassing collection of symptoms into questions that can be assessed.It also leaves room for normal variation. A body after 40 does not have to resemble a younger body to be healthy or sexually valid. The purpose of care is to address unwanted symptoms, investigate warning signs and support the person’s chosen quality of life—not to erase age.Where evidence is strong, it should be explained clearly. Where it is limited, that uncertainty should be equally visible. Conservative and medical options can be combined, reviewed and changed. A procedure with emerging evidence should never replace the assessment of pain, infection, dermatosis, pelvic-floor dysfunction or bleeding.
Educational only. Not a diagnosis or personal medical advice. Suitability is confirmed after consultation and assessment. Results vary. Not a cure.
Frequently asked questions
Concise answers to common questions; personal suitability still requires individual advice.Is vaginal dryness inevitable after menopause?
No. It is common but not universal, and severity varies. Persistent dryness can often be managed; bleeding, marked pain or unusual discharge should be assessed.
Can GSM occur while I take HRT?
Yes. Systemic HRT may help hot flushes while local genitourinary symptoms continue. NICE supports vaginal oestrogen alongside systemic HRT where appropriate.
Is vaginal oestrogen the same as systemic HRT?
No. It is low-dose local treatment and does not treat body-wide symptoms such as hot flushes. Minimal amounts enter the bloodstream compared with systemic HRT.
What if I have had breast cancer?
NICE recommends non-hormonal options first and individual consideration of vaginal oestrogen if symptoms persist, with breast-specialist involvement for people taking aromatase inhibitors.
Can pelvic-floor problems make sex painful?
Yes. Guarding or poor relaxation can contribute to entry pain. Treatment may focus on relaxation and coordination rather than strengthening alone.
Is vaginal laser proven for GSM?
Evidence remains uncertain. NICE says it should be offered for menopausal genitourinary symptoms only within a randomised controlled trial.
Should postmenopausal bleeding be assumed to be dryness?
No. Fragile tissue is one possible cause, but any vaginal bleeding after menopause should be checked.
Does having sex prevent GSM?
Sexual activity may support comfort for some people, but it is not a medical requirement. No one should force painful penetration or have sex to keep the vagina “young”.
When is examination useful?
Examination may be important for bleeding, visible change, discharge, significant pain, treatment failure or uncertainty. Testing is selected according to the pattern rather than performed automatically.
Why do UTI symptoms keep returning?
Repeated symptoms may represent recurrent bacterial infection, GSM-related urinary discomfort, an overactive bladder, urethral irritation, pelvic-floor dysfunction or another bladder condition. One person can have more than one contributor.
Bring previous urine results if available and note whether antibiotics reliably helped. Vaginal oestrogen may be discussed for recurrent-UTI prevention in the menopause context, but suspected acute infection still needs its own assessment.
Can menopause change sensation or orgasm?
Some women report change, while others do not. Sensation and orgasm are influenced by nerves, blood flow, pelvic-floor function, stimulation, pain, medicines, health, mood and relationship context as well as hormones.
A change does not prove one cause or make decline inevitable. It is useful to separate reduced sensation, difficulty becoming aroused, pain that interrupts arousal and a change in orgasm, because each points to different questions.
Can vaginal symptoms start during perimenopause?
Yes. Hormone levels fluctuate before the final period, so dryness, irritation, urinary symptoms or sexual discomfort may begin during the transition. Symptoms can be intermittent at first.
The timing supports a menopause discussion but does not exclude infection, skin disease, medicine effects or other causes. Persistent or unusual symptoms still deserve context and, when appropriate, examination or testing.
How long can vaginal oestrogen be used?
Current guidance recognises that symptoms may return when treatment stops and treatment can be restarted. Duration and review should follow the person’s symptoms, prescribed product and clinical context rather than an arbitrary universal end date.
Unexpected bleeding, new symptoms or changes in medical history should be discussed. A regular review is an opportunity to confirm benefit, technique, dose and whether the original diagnosis still fits.
How can I prepare for an appointment?
Write down the exact location and quality of the symptom: external itch, skin soreness, entry pain, internal dryness, deep pain, urethral burning, urgency or pressure. Note when it began, triggers, whether it is constant, and its effect on sleep, exercise, relationships or sex.List medicines, HRT, contraception, washes, wipes, lubricants, moisturisers and self-treatments. If you have had urine or swab tests, bring the results rather than only the label “UTI” or “thrush”. Record whether each treatment helped fully, partly or not at all.
Decide what matters most now. The priority might be pain-free daily life, comfortable examination, reducing infections, returning to penetration, stopping irritation or understanding a visible change. A clear goal helps shared decision-making without assuming that every symptom needs the same treatment.
